Politico With the Weakest Scoop on Lindsey Graham's Replacement
With Extreme Poverty at All-Time Lows, Democratic Socialists Hope to Reverse the Trend
After Ousting Graham Platner in Maine, Bernie Sanders Says President Trump Doesn't Believe...
Representation Matters in Movies, Right Up Until It Doesn't
Did Jon Ossoff Really Say This About Liberty and Supporting ICE?
CNBC Lists the Ten 'Worst' States to Live In. See If You Can...
The New York Times Explainer for Its Catch-and-Kill Report to Benefit Graham Platner
To Democrats, the Economy Is Just One Massive Jobs Program
These Three Arizona Democrats Are Backed by the Soros Family
World Cup Star Erling Haaland Made Some Hilarious Texan Purchases Before His Return...
Iranian Drones in Cuba? Here's What Trump Knows.
Rents Hit All-Time High in Mamdani's NYC As Millionaires Make Mass Exodus
Iran Launches Strikes Against Maritime Vessels in the Strait of Hormuz
Twelve Democrat States Block Paramount Merge with Warner Bros
A Grand Prix Race Heads to DC – But It Wasn't An Easy...
Tipsheet

Trump Signs Executive Order to Fast-Track Psychedelic Treatments for Mental Illness

Trump Signs Executive Order to Fast-Track Psychedelic Treatments for Mental Illness
AP Photo/Jose Luis Magana

President Donald Trump has signed an executive order to speed the use of psychedelic drugs as a potential treatment for serious mental illness. 

The order directs the Food and Drug Administration to the Commissioner’s National Priority Vouchers to appropriate psychedelic drugs that have received breakthrough therapy designations for treating serious mental illnesses. 

Advertisement

That designation aims to ensure that people with serious mental illnesses, including veterans, can receive help. America’s veterans have a suicide rate of twice that of non-veterans. For over 20 years, there have been more than 6,000 veteran suicides per year.

The Order further directs the FDA and the Drug Enforcement Agency to establish a pathway for eligible patients to access investigational psychedelic drugs, including ibogaine compounds, that are under FDA review and that have met basic safety requirements under President Trump’s landmark Right to Try Act.

The Order requires the Secretary of Health and Human Services to allocate $50 million through the Advanced Research Projects for Health program to match investments made by state governments to advance research into psychedelic programs for populations with serious mental illness.

The HHS and FDA will collaborate with the Department of Veterans Affairs and the private sector to increase clinical trial participation and evidence generation surrounding experimental psychedelic therapies. 

The order tells the Attorney General to review these drugs upon successful completion of Phase 3 clinical trials so they can be rescheduled, if appropriate. 

Advertisement

Today, over 14 million American adults have a serious mental illness— a diagnosable mental, behavioral, or emotional disorder that substantially interferes with a person’s life and ability to function.


Advertisement



Editor’s Note: Do you enjoy Townhall’s conservative reporting that takes on the radical Left and woke media? Support our work so that we can continue to bring you the truth.

Join Townhall VIP and use promo code FIGHT to receive 60% off your membership.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement